Buy eBook. Buy Hardcover.
Buy Softcover. FAQ Policy.
Neuropsychiatric Disorders An Integrative Approach
Table of contents 41 chapters Table of contents 41 chapters The meeting of minds and times with Peter Riederer: an appreciation Pages Youdim, Prof. Succi nervorum: a brief history of neurochemistry Pages Foley, P. Endogenous oxidized indoles share inhibitory potency against [3H]isatin binding in rat brain Pages Crumeyrolle-Arias, Dr. Lipid content determines aggregation of neuromelanin granules in vitro Pages Dedov, V.
Hydrogen peroxide is a true first messenger Pages Holmquist, L. Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis Pages Tribl, F. Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals Pages Wultsch, T.
Animal models in neurodegenerative diseases Pages Hirsch, Dr. Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study Pages Jellinger, K.
Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture Pages Lin, W. Pharmacokinetic studies of — -deprenyl and some of its metabolites in mouse Pages Magyar, Dr. VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly Pages Fischer, Ao. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach Pages Salkovic-Petrisic, M.
Rights and permissions
Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods Pages Teipel, S. Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder Pages Lange, Professor K. Therapeutic drug monitoring of antidepressants — clinical aspects Pages Laux, Prof. Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia Pages Nudmamud-Thanoi, S. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice Pages Pfuhlmann, PD Dr.
Neuropsychiatric Disorders An Integrative Approach | Ebook | Ellibs Ebookstore
Biostatistical analysis of gene microarrays reveals diverse expression clusters between macaque subspecies in brain SIV infection Pages Kneitz, S. Kynurenines, redox disturbances and neurodegeneration in multiple sclerosis Pages Rajda, C. The Accelerator program for Discovery in Brain disorderS ADBS is an ambitious project that will integrate clinical medicine with basic research to study mental illnesses.
The program, currently in its third year, has recently published its goals and objectives in the journal BMC Psychiatry. In the long-term, the ADBS program aims to devise novel solutions for the diagnosis and treatment of mental disorders by developing a resource base where different forms of information—clinical, genetic, biochemical, and cellular—are assimilated on a common platform. This is an important impetus to drive studies on brain disorders that focus on Indian patients.
Another significant reason for studying the genetic basis of mental illnesses in India stems from the observations made by clinicians that patients often brought in other family members for treatment of similar disorders; hinting that mental illnesses are likely to have strong heritable elements. Many elements have had to align for this program to have taken off.
Firstly, clinicians at NIMHANS have painstakingly created a cohort of deeply clinically characterized patients where the disease is highly prevalent in families. This is coupled with the high prevalence of kin marriages consanguinity amongst the Southern Indian population, providing a unique opportunity for uncovering the heritable basis for such complex disorders.
- Meet your library liaison.
- Nook Color Survival Guide.
- Sematech: saving the U.S. semiconductor industry.
Secondly, and importantly, NIMHANS and NCBS have had more than a decade of collaboration between clinicians and researchers, building trust to function in an inter-institutional effort of this magnitude. Finally, and importantly, recognizing its unique value, ADBS is generously supported by the Department of Biotechnology DBT under a larger umbrella for using stem cells as a platform for understanding the biology of chronic diseases.
A major donation from Kris and Sudha Gopalakrishnan from the Pratiksha Trust has also ensured a level of flexibility that is necessary to facilitate these partnerships. Over the last decade, advances in genome sequencing have made it possible to obtain almost the entire genetic profile of a person. Unfortunately, these advances have not translated into new knowledge for neuropsychiatry.
To do this, clinicians and researchers are using a three-pronged approach involving clinical data, genetic analyses, and cellular studies in an integrated setup that will also serve as a repository of information about mental disorders. Under the ADBS program, long-term clinical information involving detailed psychiatric evaluations, brain scans, and other parameters are being collected from families with histories of mental illnesses, where, along with patients, family members who do not develop the disorders are also evaluated.
Stem cells are undifferentiated cells that are capable of dividing almost indefinitely to form more stem cells and have the remarkable potential to develop into many different cell types. Using iPSC technology, researchers can now grow brain cells in a dish and investigate cellular changes that may occur in patients with mental disorders. Mahendra Rao. Besides this, mental illnesses often develop and progress slowly, and it may be several years before the disease is fully developed.